Cargando…

CD24Fc: an emerging COVID-19 therapy

Detalles Bibliográficos
Autores principales:	Eckhardt, Christina M, O'Donnell, Max R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916784/ https://www.ncbi.nlm.nih.gov/pubmed/35286842 http://dx.doi.org/10.1016/S1473-3099(22)00125-6

Ejemplares similares

Increased cardiovascular mortality in African Americans with COVID-19
por: McGonagle, Dennis, et al.
Publicado: (2020)

COVID-19 severity and obesity: are MAIT cells a factor?
por: McCarthy, Cormac, et al.
Publicado: (2021)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?
por: O’Donnell, Jake S., et al.
Publicado: (2016)

Multidimensional sample analysis to determine pandemic viral evolution
por: O'Donnell, Kyle L., et al.
Publicado: (2023)

Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic
por: Mohr-Holland, Erika, et al.
Publicado: (2021)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

Emerging evidence on heterologous COVID-19 vaccine schedules—To mix or not to mix?
por: Parker, Edward P K, et al.
Publicado: (2022)

Health emergency preparedness and response to the COVID-19 pandemic: Lessons learnt from Mongolia
por: Dagvadorj, Amarjargal, et al.
Publicado: (2022)

Kawasaki-like disease: emerging complication during the COVID-19 pandemic
por: Viner, Russell M, et al.
Publicado: (2020)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Passive antibody therapy in COVID-19
por: Abraham, Jonathan
Publicado: (2020)

Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients
por: Funnell, S. G. P., et al.
Publicado: (2020)

COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19
por: Velez, Juan Carlos Q., et al.
Publicado: (2020)

Emergency use authorisation for COVID-19 vaccines: lessons from Ebola
por: Smith, Maxwell J, et al.
Publicado: (2020)

The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects
por: di Filippo, Luigi, et al.
Publicado: (2021)

The emerging antimicrobial resistance crisis during the COVID-19 surge in China
por: Wang, Zhicheng, et al.
Publicado: (2023)

COVID-19 and systemic anticancer therapy: exploiting uncertainty
por: Gelderblom, Hans, et al.
Publicado: (2021)

Tuberculosis recovery in Georgia: implementing more by 24
por: Kiria, Nana, et al.
Publicado: (2022)

COVID-19: immunopathology and its implications for therapy
por: Cao, Xuetao
Publicado: (2020)

Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic
por: van Schalkwyk, May CI, et al.
Publicado: (2021)

Increasing paediatric emergency visits for suicide-related concerns during COVID-19
por: Geoffroy, Marie-Claude, et al.
Publicado: (2023)

The opening salvo of anti-complement therapy against COVID-19
por: Campbell, Courtney M
Publicado: (2020)

Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
por: Zhang, Chao, et al.
Publicado: (2020)

Cardiometabolic syndrome — an emergent feature of Long COVID?
por: Frere, Justin J., et al.
Publicado: (2022)

No perfect therapy for the imperfect COVID-19 cytokine storm
por: Cron, Randy Q
Publicado: (2022)

COVID-19: ACT trials for colchicine and antithrombotic therapies
por: Barco, Stefano, et al.
Publicado: (2022)

Electroconvulsive therapy practice during the COVID-19 pandemic
por: Bellini, Helena, et al.
Publicado: (2020)

Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020)

Kidney involvement in COVID-19 and rationale for extracorporeal therapies
por: Ronco, Claudio, et al.
Publicado: (2020)

Mental health of homeless people in China amid and beyond COVID-19
por: Su, Zhaohui, et al.
Publicado: (2022)

Mass COVID-19 vaccination of residents in geriatric facilities by emergency medical services: the Israeli experience
por: Alpert, Evan Avraham, et al.
Publicado: (2021)

From emergency response to long-term management: the many faces of the endemic state of COVID-19
por: Contreras, Seba, et al.
Publicado: (2023)

Who, what, and when—effective therapy for severe COVID-19
por: Kelmenson, Daniel A, et al.
Publicado: (2022)

Off-label therapy targeting pathogenic inflammation in COVID-19
por: Romani, Luigina, et al.
Publicado: (2020)

Challenges in lung cancer therapy during the COVID-19 pandemic
por: Calabrò, Luana, et al.
Publicado: (2020)

Impact of COVID-19 on early career scientists: an optimistic guide for the future
por: Termini, Christina M., et al.
Publicado: (2020)

Optimism and caution for an inactivated COVID-19 vaccine
por: Rostad, Christina A, et al.
Publicado: (2021)

Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19
por: Chan, Emily Ying Yang, et al.
Publicado: (2021)

Is IL-6 a key cytokine target for therapy in COVID-19?
por: Jones, Simon A., et al.
Publicado: (2021)

Non-canonical nucleosides and chemistry of the emergence of life
por: Becker, Sidney, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8e0vqsq7joiqc2sa6ji9k0cefh